HER2-positive breast cancer

Tanvex BioPharma USA

Company1 trialPhase 3809 people

Innovent Biopharmaceutical Technology

Company1 trialPhase 3540 people

Prestige Biopharma

Company1 trialPhase 3503 people

Cinnagen

Company1 trialPhase 3214 people

Sichuan Baili Pharmaceutical

Company1 trialPhase 2/3985 people

Jazz Pharmaceuticals

Company1 trialPhase 2125 people

Beijing Biotech

Company1 trialPhase 1/260 people

Enliven Therapeutics

Company1 trialPhase 1275 people